This NIH grant opportunity is aimed at small businesses conducting research and development of pharmaceutical interventions to extend lifespan and/or healthspan for Alzheimer’s disease (AD) and Alzheimer’s disease related dementia (ADRD) in various models. The focus is on preventing, treating, and slowing the progression of symptoms associated with AD/ADRD. Applications utilizing human cells, tissue, in-vitro models, and non-human animals are encouraged. The closing date for this grant is January 5, 2021.
Opportunity ID: 299565
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-512 |
| Funding Opportunity Title: | Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.866 — Aging Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 20, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jan 05, 2021 |
| Current Closing Date for Applications: | Jan 05, 2021 |
| Archive Date: | Feb 10, 2021 |
| Estimated Total Program Funding: | $4,000,000 |
| Award Ceiling: | $350,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This funding opportunity (FOA) encourages small business-based (SBIR) research and development of commercial pharmaceutical interventions to extend lifespan and/or healthspan, to prevent, treat, and/or slow the progression of symptoms associated with Alzheimer’s disease (AD) and Alzheimer’s disease related dementia (ADRD) in human cells and/or tissue, in-vitro models, and/or non-human animals. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-512.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00237165 | Mar 05, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260342 | Mar 05, 2018 | Jan 05, 2021 | View |
Package 1
Mandatory forms
299565 RR_SF424_2_0-2.0.pdf
299565 PHS398_CoverPageSupplement_4_0-4.0.pdf
299565 RR_OtherProjectInfo_1_4-1.4.pdf
299565 PerformanceSite_2_0-2.0.pdf
299565 RR_KeyPersonExpanded_2_0-2.0.pdf
299565 RR_Budget_1_4-1.4.pdf
299565 PHS398_ResearchPlan_4_0-4.0.pdf
299565 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
299565 RR_SubawardBudget30_1_4-1.4.pdf
299565 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
299565 RR_SF424_2_0-2.0.pdf
299565 PHS398_CoverPageSupplement_5_0-5.0.pdf
299565 RR_OtherProjectInfo_1_4-1.4.pdf
299565 PerformanceSite_2_0-2.0.pdf
299565 RR_KeyPersonExpanded_2_0-2.0.pdf
299565 RR_Budget_1_4-1.4.pdf
299565 PHS398_ResearchPlan_4_0-4.0.pdf
299565 SBIR_STTR_Information_1_3-1.3.pdf
299565 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
299565 RR_SubawardBudget30_1_4-1.4.pdf
299565 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
